CDTI has just published the proposed provisional resolution of the call for aid for direct and associated participants in the Major Project of Common European Interest in Health (Med4Cure), launched by the CDTI.
The SYOLIGO project, RNA-based therapies for rare diseases: R&D for competitive and sustainable oligonucleotide production, has received 100% funding of the budget submitted for January 2023 to August 2026 (21.1 million euros within the framework of the Recovery, Transformation and Resilience Plan).



